|
Search
Collections
Benchmarks
Upload document
Product
Antitumor B
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Oral Squamous Cell Carcinoma
Clinical trial
PK Analysis of Antitumor B in Patients With Oral Cancer
Status: Active (not recruiting)
, Estimated PCD: 2022-02-15
